[1]
Molica, S., Sportoletti, P., Di Renzo, N. , Musto, P., Pane, F. and Di Raimondo, F. 2021. Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy. Mediterranean Journal of Hematology and Infectious Diseases. 13, 1 (Jun. 2021), e2021042. DOI:https://doi.org/10.4084/MJHID.2021.042.